The medicalisation of "ups and downs": the marketing of the new bipolar disorder

scientific article published on 7 April 2014

The medicalisation of "ups and downs": the marketing of the new bipolar disorder is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1363461514530024
P698PubMed publication ID24709668
P5875ResearchGate publication ID261442687

P50authorJoanna MoncrieffQ16732770
P2860cites workDSM-5Q3064664
Pharmacologic treatments for pediatric bipolar disorder: a review and meta-analysisQ37904401
The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV.Q41033540
Juvenile mood disorders and office psychopharmacologyQ41662406
Issues for DSM-5: whither melancholia? The case for its classification as a distinct mood disorderQ42537686
Open-label, 8-week trial of olanzapine and risperidone for the treatment of bipolar disorder in preschool-age childrenQ46765699
Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapineQ46921511
New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigineQ47883104
A prospective open-label trial of quetiapine monotherapy in preschool and school age children with bipolar spectrum disorder.Q50997499
Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania.Q51032804
Mood variability in normal subjects on lithium.Q51138478
The effects of lithium carbonate on healthy volunteers: mood stabilization?Q51168933
National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.Q51801492
The impact of mood stabilizers on bipolar disorder: the 1890s and 1990s compared.Q53259505
The latest mania: selling bipolar disorderQ21090149
Increasing off-label use of antipsychotic medications in the United States, 1995-2008Q24628874
The subjective experience of taking antipsychotic medication: a content analysis of Internet dataQ33409973
Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia.Q33814201
The soft bipolar spectrum redefined: focus on the cyclothymic, anxious-sensitive, impulse-dyscontrol, and binge-eating connection in bipolar II and related conditionsQ33962900
Discontinuing lithium maintenance treatment in bipolar disorders: risks and implicationsQ34188583
Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010.Q34263186
Treatment guidelines for children and adolescents with bipolar disorderQ36052032
Risk of Recurrence Following Discontinuation of Lithium Treatment in Bipolar DisorderQ37152810
Adolescent experience of psychotropic treatmentQ37369440
The promotion of olanzapine in primary care: an examination of internal industry documentsQ37501057
The bipolar spectrum: a critical perspectiveQ37508848
P433issue4
P921main subjectbipolar disorderQ131755
P304page(s)581-598
P577publication date2014-04-07
P1433published inTranscultural PsychiatryQ7833943
P1476titleThe medicalisation of "ups and downs": the marketing of the new bipolar disorder
P478volume51

Reverse relations

cites work (P2860)
Q48126581"Being Bipolar": A Qualitative Analysis of the Experience of Bipolar Disorder as Described in Internet Blogs
Q48299118Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of users.
Q36947471Developing a psychiatrist-patient relationship when both people are doctors: a qualitative study
Q92053962Pre-pubertal bipolar disorder: origins and current status of the controversy

Search more.